At 16.2% CAGR, Global NK Cell Therapy Market Size to Surpass USD 856.2 Million by 2027 | NK Cell Therapy Industry Developments, Share, Trends, Demand, Revenue, Key Findings, Technology, Expansion Strategies, Analysis and Forecast
May 26, 2022 08:43 ET
|
Industry Research
Pune, May 26, 2022 (GLOBE NEWSWIRE) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global “NK Cell Therapy Market” Research Report 2021-2027 is a historical...
Global Adoptive Cell Therapy Market to Surpass US$ 23,440.7 Million by 2030, Says Coherent Market Insights (CMI)
March 11, 2022 09:10 ET
|
CMI
SEATTLE, March 11, 2022 (GLOBE NEWSWIRE) -- According to coherent market insights, the global adoptive cell therapy market is estimated to be valued at US$ 4, 932.5 million in 2022 and is expected...
Alphageneron to Participate in the ROTH Virtual Healthcare Private Company Forum on June 28th, 2021
June 25, 2021 19:21 ET
|
Alphageneron Pharmaceuticals
CAMBRIDGE, Mass., June 25, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc. (“Alphageneron” or the “Company”), a privately-held clinical-stage biopharmaceutical company developing...
Sorrento and Celularity to Initiate Emergency Allogeneic Natural Killer (NK) Cell Therapy Development for Coronavirus Infection
January 29, 2020 07:00 ET
|
Sorrento Therapeutics, Inc.
SAN DIEGO and WARREN, N.J., Jan. 29, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") announced it has initated a clinical and manufacturing collaboration with...